unknown
Stage
2
Investors
About
Endotronix develops the Cordella system, an FDA-approved remote monitoring device that measures pulmonary artery pressure and vital signs to enable proactive management of NYHA class III heart failure patients, aiming to reduce hospitalizations and improve patient outcomes.
Explore Endotronix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.